Biotech Bonanza Sees BSLK Explode 446% as Small Caps Skyrocket
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap – August 13, 2025
Overview
On Wednesday, the U.S. equity market saw pronounced strength in small- and micro-cap names, particularly within the biotech and specialty sectors. A string of double- and triple-digit gainers drove heavy trading, as investors gravitated toward beaten-down issues with upcoming catalysts. Market breadth was narrow, with a handful of stocks accounting for much of the day’s volume and volatility.
Intraday Prices and Volume
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| BSLK | 2.0080 | 10.9787 | 148,840,984 | 446.73% |
| VOR | 1.6957 | 2.0000 | 15,889,415 | 17.95% |
| GBIO | 4.8150 | 6.5000 | 7,042,229 | 34.95% |
| MNTS | 1.1310 | 1.8400 | 170,023,593 | 62.67% |
| SPNS | 42.2360 | 42.5004 | 9,618,206 | 0.61% |
| WBTN | 11.7250 | 17.0000 | 9,361,241 | 44.99% |
| CGTX | 1.0080 | 1.2898 | 24,040,109 | 27.83% |
| HBM | 10.3790 | 11.3900 | 12,673,377 | 9.80% |
| ADD | 0.1142 | 0.1799 | 40,949,298 | 57.49% |
| CAVA | 63.7800 | 70.4500 | 22,999,274 | 10.43% |
| SHOT | 0.4480 | 0.6183 | 37,572,295 | 38.00% |
| KLC | 6.4330 | 7.8800 | 3,410,127 | 22.52% |
| EDIT | 2.3790 | 3.0896 | 5,134,196 | 29.92% |
| ACDC | 3.3200 | 3.6701 | 9,622,926 | 10.56% |
| SRFM | 4.0820 | 4.9900 | 7,644,330 | 22.30% |
| LGVN | 0.5870 | 0.8000 | 12,789,857 | 36.23% |
| OVID | 0.4610 | 0.7800 | 6,077,132 | 69.09% |
| SMWB | 7.3570 | 8.2900 | 562,285 | 12.71% |
| FATE | 0.8800 | 1.1494 | 3,983,910 | 30.53% |
| RSLS | 1.4810 | 2.9406 | 26,461,397 | 98.53% |
Biotech stocks by CHUTTERSNAP
Market Trends and Patterns
Trading today was dominated by speculative biotech and low-float stocks. More than half of the tabled names recorded gains exceeding 30%, and five issues—BSLK, RSLS, MNTS, OVID and ADD—surpassed 50% gains. Volume was heavily skewed toward the largest movers, with MNTS and BSLK each trading north of 140 million shares, illustrating a chase into high-beta names.
Sector rotation appeared limited: while restaurant chain CAVA posted a modest 10% advance, and SPNS held flat, most large-cap and mid-cap indices drifted in narrow ranges. This suggests a risk-on appetite for headline-grabbing stories, as investors hunt for outsized returns in small caps ahead of potential clinical or regulatory developments.
Notable Movers
- BSLK led the rally with a 446.7% jump. The stock more than quintupled from its prior close, fueled by surge volume of 149 million shares.
- RSLS nearly doubled on heavy trading interest tied to an upcoming merger and Nasdaq rebranding.
- OVID jumped 69.1% as news of a royalty deal and cash runway extension circulated.
- MNTS rallied 62.7% amid effective S-1 clearance and anticipation of new space demonstrations.
- ADD surged 57.5% with nearly 41 million shares changing hands after announcements on reverse split plans.
Meanwhile, SPNS saw limited movement, rising just 0.6% on thin volume relative to its float.
TL;DR
On August 13, 2025, market strength concentrated in small-cap biotech and specialty stocks. BSLK soared 446.7% on 149 million shares, while RSLS, OVID, MNTS and ADD each gained over 50% on outsized volume. Major indices remained range-bound as investors rotated into high-beta, event-driven names.